Biochemistry, Genetics and Molecular Biology
Telomere
100%
Telomere Length
65%
Alpha Thalassemia/Mental Retardation X-Linked
32%
Cancer Cell
29%
Telomerase
24%
Carcinogenesis
19%
Micrococcal Nuclease
19%
Stromal Cell
17%
Telomere Shortening
14%
Fluorescence in Situ Hybridization
13%
Genetics
11%
Mouse
11%
Promoter Region
11%
Amino Acids
10%
Denaturation
10%
Androgen Receptor
10%
Leukocyte
9%
Telomerase Reverse Transcriptase
9%
Tissue Microarray
9%
Denatured State
8%
Wild Type
7%
Chromosome Instability
7%
P53
7%
Allele
7%
Alanine
7%
IDH1
7%
Telomere Homeostasis
7%
Genome Instability
7%
P21
6%
Stem Cell
6%
Estrogen Receptor
6%
Epigenetics
6%
Nuclease
6%
TMPRSS2
6%
Gene Expression
6%
BRCA1
6%
Tumor Suppressor Protein
6%
Upregulation
5%
Precursor
5%
DNA Damage Response
5%
Keyphrases
Telomere Length
49%
Telomere
42%
Prostate Cancer
40%
Telomere Shortening
24%
Short Telomere
17%
Telomerase
16%
Tumor
15%
Cancer Cells
13%
Prostate Cancer Cells
12%
Prostate Stromal Cells
11%
Immunohistochemistry
10%
Stromal Cells
10%
In Cancer
9%
Tissue Microarray
8%
Human Telomerase Reverse Transcriptase (hTERT)
8%
Treg
8%
Tumor Microenvironment
8%
Fluorescence in Situ Hybridization
8%
Early Events
8%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
8%
Telomerase Activity
7%
Prostate Cancer Risk
7%
Human Prostate
7%
Quantitative PCR
7%
Androgen Receptor Splice Variant 7
6%
Cancer Resistance
6%
Androgen Receptor Antagonist
6%
2nd Generation
6%
Programmed Death-ligand 1 (PD-L1)
6%
Human Epidermal Growth Factor Receptor 2 (HER2)
6%
Cellular Senescence
6%
Metastasis
6%
Primary Prostate Cancer
6%
Telomere Dysfunction
5%
Overexpression
5%
Human Cancer
5%
Prostatic Adenocarcinoma
5%
DNA Damage Response
5%
Glioma
5%
Staphylococcal nuclease
5%
Tumor-infiltrating Lymphocytes
5%
Prostate
5%
Senescence
5%
In Situ Hybridization
5%
Pancreatic Neuroendocrine Tumors (pNETs)
5%
Breast Cancer
5%
Medicine and Dentistry
Prostate Cancer
35%
Neoplasm
26%
Telomere
24%
Malignant Neoplasm
18%
Programmed Death-Ligand 1
11%
Androgen Receptor
11%
Ganglioglioma
10%
Immunohistochemistry
10%
Carcinogenesis
8%
Tissue Microarray
8%
Cancer Cell
7%
Glioblastoma
7%
Gene Fusion
7%
Prostate Adenocarcinoma
7%
Tumor Microenvironment
7%
Transitional Cell Carcinoma
6%
Oncogene
6%
Tumor Infiltrating Lymphocyte
6%
Adenocarcinoma
6%
Cellular Senescence
5%
Telomerase Reverse Transcriptase
5%
High-Grade Prostatic Intraepithelial Neoplasia
5%
Epileptic Absence
5%
Metastatic Carcinoma
5%
Breast Cancer
5%
Carcinoma
5%
Precursor
5%
Estrogen Receptor
5%
Fluorescence in Situ Hybridization
5%
in Situ Hybridization
5%
Tumor Immune Microenvironment
5%
Cell Proliferation
5%
